Jim Ziegler
Corporate Officer/Principal at IOVANCE BIOTHERAPEUTICS, INC.
Profile
Jim Ziegler is currently the Executive Vice President-Commercial at Iovance Biotherapeutics, Inc. He previously held positions as the Head-Sales & Marketing at Amgen, Inc., Gilead Sciences, Inc., Pfizer Inc., Biogen, Inc., and Nodality, Inc. He also served as the Vice President-Sales & Marketing at Nodality, Inc. and as a Principal in The United States Army (District of Columbia).
Mr. Ziegler holds an MBA from The University of Chicago and an undergraduate degree from the US Military Academy.
Jim Ziegler active positions
Companies | Position | Start |
---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 31/01/2020 |
Former positions of Jim Ziegler
Companies | Position | End |
---|---|---|
The United States Army (District of Columbia) | Corporate Officer/Principal | - |
GILEAD SCIENCES, INC. | Sales & Marketing | - |
BIOGEN INC. | Sales & Marketing | - |
AMGEN INC. | Sales & Marketing | - |
PFIZER, INC. | Sales & Marketing | - |
Training of Jim Ziegler
The University of Chicago | Masters Business Admin |
US Military Academy | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
AMGEN INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
BIOGEN INC. | Health Technology |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Health Technology |
The United States Army (District of Columbia) | Government |
- Stock Market
- Insiders
- Jim Ziegler